miRNAs: Little known mediators of oncogenesis

Andrei L Gartel1, Eugene S Kandel

  • 1Department of Medicine, University of Illinois at Chicago, 840, South Wood Street, Room 1041, Chicago, IL 60612, United States. agartel@uic.edu

Seminars in Cancer Biology
|February 26, 2008
PubMed

Insights

MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression and are increasingly recognized for their roles in cancer. This study reviews methods for identifying cancer-related miRNAs and their mRNA targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cancer progression involves oncogenes and tumor suppressors.
  • MicroRNAs (miRNAs), small non-coding RNAs, are emerging regulators of gene expression.
  • miRNAs are implicated in both promoting and suppressing tumorigenesis across various tissues.

Purpose of the Study:

  • To review the role of miRNAs in cancer progression.
  • To discuss methodologies for identifying cancer-related miRNAs.
  • To evaluate approaches for determining miRNA-mRNA targets.

Main Methods:

  • Literature review of published results.
  • Analysis of expression profiling data.
  • Functional validation using forward and reverse genetics.

Main Results:

  • A growing body of evidence links specific miRNAs to cancer development.
  • Various genetic and expression profiling techniques are used to identify these miRNAs.
  • Challenges exist in validating miRNA-cancer associations and target interactions.

Conclusions:

  • MicroRNAs are critical players in cancer biology.
  • Robust methodologies are essential for accurate identification and validation of cancer-related miRNAs.
  • Understanding miRNA functions is key to developing novel cancer therapies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...